HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cilostazol research in Asia: can it be applied to European and American patients?

Abstract
Cilostazol is an antiplatelet drug often used in Asian countries like Korea, Japan, and China. However, it is rarely used in the west. Cilostazol inhibits phosphodiesterase, increases cyclic AMP concentrations, and consequently inhibits platelet aggregation. Interestingly, it also has vasodilatory activity, inhibits vascular smooth muscle proliferation, and protects the endothelium. Studies in Asia have shown that cilostazol is effective in the secondary prevention of stroke. Moreover, it is significantly less likely to cause bleeding complications than aspirin. Additional trials have shown that cilostazol is effective in the prevention of intracranial atherosclerosis progression. Unfortunately, cilostazol has rarely been studied in non-Asian stroke patients and, accordingly, the benefits of cilostazol are less well appreciated in Europe and America than in Asia. Although further studies are required, we suggest that at least some stroke patients (e.g., patients prone to bleeding, patients with intracranial atherosclerosis, etc.) may readily benefit from cilostazol regardless of ethnicity.
AuthorsJong S Kim, Sun U Kwon, Shinichiro Uchiyama
JournalInternational journal of stroke : official journal of the International Stroke Society (Int J Stroke) Vol. 10 Suppl 1 Pg. 1-9 (Mar 2015) ISSN: 1747-4949 [Electronic] United States
PMID25736819 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 World Stroke Organization.
Chemical References
  • Platelet Aggregation Inhibitors
  • Tetrazoles
  • Phosphoric Diester Hydrolases
  • Cilostazol
Topics
  • Asia (ethnology)
  • Cilostazol
  • Europe (ethnology)
  • Hemorrhage (epidemiology, prevention & control)
  • Humans
  • Intracranial Arteriosclerosis (drug therapy, epidemiology)
  • Phosphoric Diester Hydrolases (therapeutic use)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Secondary Prevention (methods)
  • Stroke (epidemiology, prevention & control)
  • Tetrazoles (adverse effects, therapeutic use)
  • United States (ethnology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: